13F Holdings
中文EN

UPB Upstream Bio, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 2022626 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY2.5%
TTM net income YoY-34.1%
TTM EPS YoY-128.2%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-6,116.0%
Net margin-5,712.3%
FCF margin—
EBITDA margin-6,108.9%

Returns

ROE-53.5%
ROA-51.5%
ROIC (approx.)-56.3%
Asset turnover0.01x

Leverage & solvency

Liabilities / assets4.9%
Debt / equity0.00x
Current ratio20.45x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.03x
Accruals ratio1.4%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31
Income statement
Revenue$2.85M$2.37M$2.38M
R&D expense$136.81M$62.97M$31.80M
SG&A expense$26.41M$17.17M$10.70M
Operating income-$160.36M-$77.76M-$40.11M
Income tax$0$0$0
Net income-$143.44M-$62.81M-$20.54M
EBITDA-$160.17M-$77.67M-$40.05M
EPS (basic)-2.66-5.58-12.95
EPS (diluted)-2.66-5.58-12.95
Weighted avg. shares (diluted)53.85M13.68M2.95M
Balance sheet
Cash & equivalents$101.58M$325.89M$25.83M
Short-term investments$239.93M$144.56M$83.98M
Receivables$668,000$613,000$98,000
Current assets$351.80M$479.16M$117.00M
PP&E, net$559,000$582,000$159,000
Goodwill—$0—
Total assets$353.77M$481.72M$117.20M
Current liabilities$13.45M$10.74M$6.51M
Total liabilities$14.00M$11.87M$9.39M
Shareholders' equity$339.77M$469.85M-$123.13M
Shares outstanding54.24M53.60M2.99M
Cash flow statement
Operating cash flow-$133.28M-$59.17M-$37.93M
Capital expenditure$165,000$511,000$144,000
Free cash flow-$133.44M-$59.68M-$38.07M
Investing cash flow-$93.48M-$59.48M-$82.84M
Financing cash flow$2.44M$418.91M$129.55M
Depreciation & amortization$188,000$89,000$60,000
Stock-based compensation$10.33M$6.00M$3.33M

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.